Ankur Bansal is an experienced professional in the pharmaceutical and regulatory sectors, currently serving as Associate Director at AstraZeneca since June 2022, focusing on submission excellence and regulatory insights for CMC planning. Prior to this role, Ankur held various positions including Senior Scientist in Virology R&D at Biocon, where responsibilities encompassed analytical method development and validation, and earlier roles in regulatory affairs and quality analysis. Ankur's career also includes significant contributions at Eli Lilly and Company, involved in CMC authoring and regulatory submissions across diverse global markets. Ankur holds a Bachelor of Pharmacy degree from Rajiv Gandhi University of Health Sciences, completed in 2004.
This person is not in the org chart
This person is not in any teams
This person is not in any offices